Supervised atenolol therapy in the management of hemodialysis hypertension.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Uncontrolled hypertension continues to be a common problem, particularly in noncompliant hemodialysis patients. Atenolol, a water soluble beta-blocker has a prolonged half-life in renal failure and may serve as a useful antihypertensive agent in these patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Kidney Int.

Title: Kidney international

ISSN: 0085-2538

ISSN (Print): 0085-2538

Publication date (Electronic): Apr 1999

Volume: 55

Issue: 4

Affiliations

[1 ] Department of Medicine, Indiana University and RLR VA Medical Center, Indianapolis, USA. ragarwal@iupui.edu

Article

Publisher Item ID: S0085-2538(15)46108-3

DOI: 10.1046/j.1523-1755.1999.00359.x

PubMed ID: 10201019

SO-VID: 34116ca1-d07e-483b-8d29-9b9c6a85172b

History

Data availability:

Comments

Comment on this article

scite_

Cited by 20

See all cited by